LC-MS/MS method development and validation for the determination of antiviral drug in human plasma
Keywords:
Bioanalysis, HPLC-ESI-MS/MS, Human plasma, DarunavirAbstract
The validated protein precipitation method was applied to estimate Darunavir in human plasma with Verapamil as an internal standard. The analytical column was selected Agilent, Zorbax, and XDB C18 (2.1 x 50 mm ID, 5 μm). The column temperature was set at 30°C. The mobile phase composition was acetonitrile:2Mm Ammonium Formate with 0.1% formic acid in water (70:30 v/v). Source flow rate at 0.120 mL/min without a split. An injection volume of 10 µL. Darunavir and Verapamil were eluted at 1.35 &1.13 min, with a total run time of 3.0 min for each sample
Downloads
References
Ana Carolina Kogawa, Hérida Regina Nunes Salgado, Development and Validation of Infrared Spectroscopy Method for the Determination of Darunavir in Tablets, Journal of Physical Chemistry, 3, 2013, 1-6.
Ganduri RB, Lanka RA, Pamidi, Peddareddigari JR, Rao JVLNS, New RP-HPLC method development of Darunavir in tablet dosage form, Asian Journal of Pharmaceutical Research, 1(1), 2011, 10-14.
Goldwirt L, Chhuna S, Rey E, Launay O, Viard P, Pons p, Jullien V, Quantification of Darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detection, Journal of Chromatography B, 857, 2007, 327-331.
http://www.rxlist.com/ norvir-drug.htm.
Kanneti R, Jaswanth KL, Neeraja KR, Bhat PA, Development and validation of lc-ms/ms method for determination of Darunavir in human plasma for application of clinical pharmacokinetics, International Journal of Pharmacy and Pharmaceutical Sciences, 3(5), 2011, 0975-1491.
Kiado A, A simple and sensitive HPTLC method for quantitative analysis of Darunavirethanolate tablets, Journal of Planar Chromatography - Modern TLC, 24(3), 2011, 232-235.
Padmiswari, A. A. I. M., Wulansari, N. T., Antari, N. W. S., Damayanti, I. A. M., Indrayoni, P., & Indrawan, G. S. (2021). The effectiveness of soaking duration on blood cockles (Anadara granosa) with activated charcoal towards reducing metals lead (Pb). International Journal of Health & Medical Sciences, 4(3), 304-308. https://doi.org/10.21744/ijhms.v4n3.1756
Patel BN, Suhagia BN, Patel CN, RP-HPLC method development and validation for estimation of Darunavirethanolate in tablet dosage form, International Journal of Pharmacy and Pharmaceutical Sciences, 4(3), 2012, 270-273.
Patel BN, Suhagia BN, Simultaneous Determination And Validation Of DarunavirEthanolate And Ritonavir In Binary Mixture By Liquid Chromatography, International Journal of PharmTech Research, 4, 2012, 1450-1456.
Ramesh, Bokka, Ramakrishna, Sisla, Reddy, Rentam Kiran Kumar, babu, Kothapalli Hari, Sarma, Vanka Uma Maheswara Devi, PotturiSita, HPTLC method for determination of Darunavir in rat plasma and its application in pharmacokinetic studies, Journal of Liquid Chromatography & Related Technologies, 36(2), 2013, 167-179.
Rami BV, Reddy G. Jyothi , Reddy BS, Raman N.V.V.S.S, K. Reddy SC, Rambabu C, Stability-Indicating HPLC Method for the Determination of DarunavirEthanolate, Journal of Chromatographic Science, 2012, 471-476.
Satyanarayana L, Naidu SV, Rao MN, Kumar A, Suresh K, The Estimation of Darunavir in Tablet dosage form by RP-HPLC, Asian Journal of Research Pharmaceutical Science, 1(3), 74-76.
Shinde VR, Gosavi SA, Pawar SS, Kasture VS, Musmade DS, Development and validation of uv spectroscopic method for determination of Darunavir in bulk and tablet formulation, Inventi Rapid: Pharm Analysis & Quality Assurance, 1, 2013, 586-587.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
